| Identification | Back Directory | [Name]
DEOXYLIMONIN | [CAS]
989-23-1 | [Synonyms]
DEOXYLIMONIN
desoxylimonin
4H,6H,8H-Pyrano[4',3':3,3a]isobenzofuro[5,4-f][2]benzopyran-4,11,13(7H,14H)-trione, 9-(3-furanyl)-1,2a,3,6b,8a,9,12b,14a-octahydro-1,1,8a,12b-tetramethyl-, (2aS,6aR,6bR,8aR,9R,12bR,14aR)- (9CI) | [Molecular Formula]
C26H30O7 | [MDL Number]
MFCD33023253 | [MOL File]
989-23-1.mol | [Molecular Weight]
454.51 |
| Hazard Information | Back Directory | [Uses]
Desoxylimonin is an orally active triterpenoid compound found from grapefruit seed. Desoxylimonin shows anti-proliferative activities to breast cancer cells. Desoxylimonin derivatives shows better anticancer, analgesic and anti-inflammatory activity than the lead compound[1]. | [Definition]
ChEBI: Desoxylimonin is a steroid lactone. | [in vivo]
Deoxylimonin (oral administration; 70 mg/kg; once) treatment shows antinociception effects in vivo[1]. | Animal Model: | Mice injected with acetic acid[1] | | Dosage: | 70 mg/kg | | Administration: | Oral administration; 70 mg/kg; once | | Result: | Showed the antinociception efficacy (writhing inhibition rate: 24.61%). |
| [storage]
4°C, protect from light | [References]
[1] Shaochi Wang, et al. Discovery of deoxylimonin δ-lactam derivative with favorable anti-inflammation and antinociception efficacy from chemical modified limonin/deoxylimonin analogs. Bioorg Chem. 2020 Jul;100:103886. DOI:10.1016/j.bioorg.2020.103886
[2] N. Guthri, et al. Inhibition of Human Breast Cancer Cells by Citrus Limonoids. ACS Symposium SeriesVol. 758, July 30, 2000. |
|
| Company Name: |
Henan Alfachem Co.,Ltd.
|
| Tel: |
0371-55051623 18137891487 |
| Website: |
www.chemicalbook.com/supplier/14555231/ |
|